Antiviral Therapy

Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young-Suk Lim

Gut Apr 2024, 73 (4) 649-658; DOI: 10.1136/gutjnl-2023-330225
Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion
Yang Wang, Qiqi Li, Cheng Li, Cong Wang, Shijie Wang, Wenjie Yuan, Demin Yu, Ke Zhang, Bisheng Shi, Xiaomei Chen, Tiantian Liu, Zhenghong Yuan, Shuping Tong, Michael Nassal, Yu-Mei Wen, Yong-Xiang Wang

Gut Apr 2024, 73 (4) 668-681; DOI: 10.1136/gutjnl-2023-330537
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target
Eloi R Verrier, Gaëtan Ligat, Laura Heydmann, Katharina Doernbrack, Julija Miller, Anne Maglott-Roth, Frank Jühling, Houssein El Saghire, Margaux J Heuschkel, Naoto Fujiwara, Sen-Yung Hsieh, Yujin Hoshida, David E Root, Emanuele Felli, Patrick Pessaux, Atish Mukherji, Laurent Mailly, Catherine Schuster, Laurent Brino, Michael Nassal, Thomas F. Baumert

Gut Sep 2023, 72 (9) 1745-1757; DOI: 10.1136/gutjnl-2020-323665
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban, Christoph Neumann-Haefelin, Pietro Lampertico

Gut Sep 2021, 70 (9) 1782-1794; DOI: 10.1136/gutjnl-2020-323888
Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection
Caorui Lin, Linjie Luo, Zhen Xun, Chenggong Zhu, Ying Huang, Yuchen Ye, Jiawei Zhang, Tianbin Chen, Songhang Wu, Fuguo Zhan, Bin Yang, Can Liu, Ning Ran, Qishui Ou

Gut Feb 2024, 73 (2) 338-349; DOI: 10.1136/gutjnl-2023-330389
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
Rani Burm, Panagiota Maravelia, Gustaf Ahlen, Sandra Ciesek, Noelia Caro Perez, Anna Pasetto, Stephan Urban, Freya Van Houtte, Lieven Verhoye, Heiner Wedemeyer, Magnus Johansson, Lars Frelin, Matti Sällberg, Philip Meuleman

Gut Jun 2023, 72 (6) 1186-1195; DOI: 10.1136/gutjnl-2022-327216
Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis
Samuel Anthony Lachlan Hall, Sara Vogrin, Olivia Wawryk, Gareth S Burns, Kumar Visvanathan, Vijaya Sundararajan, Alexander Thompson

Gut Aug 2022, 71 (8) 1629-1641; DOI: 10.1136/gutjnl-2020-323979
Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China
Calvin Q. Pan, Erhei Dai, Zhongping Duan, Guorong Han, Wenjing Zhao, Yuming Wang, Huaihong Zhang, Baoshen Zhu, Hongxiu Jiang, Shuqin Zhang, Xiaohu Zhang, Huaibin Zou, Xiuli Chen, Yu Chen

Gut Apr 2022, 71 (4) 798-806; DOI: 10.1136/gutjnl-2020-322719
Ponder of concern and long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil
Ankur Jindal, Ashish Vyas, Garima Dubey

Gut Apr 2022, 71 (4) 840-841; DOI: 10.1136/gutjnl-2021-324967
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma
Ruben Hernaez, Robert Thimme

Gut Mar 2022, 71 (3) 454-456; DOI: 10.1136/gutjnl-2021-324288

Main menu

Antiviral Therapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Antiviral Therapy

Pages